Rankings
▼
Calendar
LIVN Q3 2025 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q3 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$358M
+12.5% YoY
Gross Profit
$245M
68.4% margin
Operating Income
$54M
15.1% margin
Net Income
$27M
7.5% margin
EPS (Diluted)
$0.49
QoQ Revenue Growth
+1.5%
Cash Flow
Operating Cash Flow
$85M
Free Cash Flow
$62M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$2.6B
Total Liabilities
$1.4B
Stockholders' Equity
$1.2B
Cash & Equivalents
$646M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$358M
$318M
+12.5%
Gross Profit
$245M
$225M
+8.7%
Operating Income
$54M
$36M
+51.6%
Net Income
$27M
$33M
-18.7%
Revenue Segments
Cardiopulmonary Segment
$203M
58%
Neuromodulation Segment
$150M
42%
Geographic Segments
UNITED STATES
$190M
53%
Locations Excluding The United States And Europe
$100M
28%
Europe
$68M
19%
← FY 2025
All Quarters
Q4 2025 →